Search

Kamil Paruch

from Hillsborough, NJ
Age ~52
Get Report
Also known as:
Kamil Paruchova, Paruch Paruch, Kamil Paruc, Kamio Paruchova, Kamil M
Phone and address:
744 Robin Rd, Millstone, NJ 08844
(908) 789-1284
Related to:
Jaroslava Paruchova, 53
Connected to:
Adam Paruch, 51David H Paruch, 77Gretchen Paruch, 74Robert B Paruch, 72Bhavya Paruchuri, 38Himaja Paruchuri, 55Ramoj K Paruchuri, 66Satish K Paruchuri, 41Sita Paruchuri, 70John M Parucki, 77

Kamil Paruch Phones & Addresses

  • 744 Robin Rd, Hillsborough, NJ 08844 (908) 789-1284
  • 20 3Rd Ave, Garwood, NJ 07027 (732) 789-1284 (908) 789-1284
  • 21 Springfield Ave, Cranford, NJ 07016 (908) 709-1711
  • 512 Westfield Ave, Westfield, NJ 07090
  • New York, NY

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: High school graduate or higher

Publications

Us Patents

Imidazopyrazines As Cyclin Dependent Kinase Inhibitors

View page
US Patent:
6919341, Jul 19, 2005
Filed:
Sep 19, 2003
Appl. No.:
10/665005
Inventors:
Kamil Paruch - Garwood NJ, US
Timothy J. Guzi - Chatham NJ, US
Michael P. Dwyer - Scotch Plains NJ, US
Ronald J. Doll - Convent Station NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Alan Mallams - Hackettstwon NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D487/04
A61K031/495
US Classification:
514249, 544350
Abstract:
In its many embodiments, the present invention provides a novel class of imidazo[1,2-a]pyrazine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

17-Β Hydroxysteroid Dehydrogenase Type 3 Inhibitors For The Treatment Of Androgen Dependent Diseases

View page
US Patent:
6969718, Nov 29, 2005
Filed:
Oct 15, 2002
Appl. No.:
10/271358
Inventors:
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Cranford NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K031/497
C07D401/00
US Classification:
51425301, 544360
Abstract:
There are disclosed compounds of the formula (I): prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases.

Imidazopyridines As Cyclin Dependent Kinase Inhibitors

View page
US Patent:
6992080, Jan 31, 2006
Filed:
Sep 17, 2003
Appl. No.:
10/664338
Inventors:
Michael P. Dwyer - Scotch Plains NJ, US
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Ronald J. Doll - Convent Station NJ, US
Kartik M. Keertikar - East Windsor NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/435
A61K 31/505
A61K 31/44
C07D 471/02
C07D 401/14
US Classification:
51421707, 514303, 514300, 51425304, 514256, 544362, 544333, 546121, 546113
Abstract:
In its many embodiments, the present invention provides a novel class of imidazo[1,2-a]pyridine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

Pyrazolotriazines As Kinase Inhibitors

View page
US Patent:
7038045, May 2, 2006
Filed:
Feb 23, 2005
Appl. No.:
11/064044
Inventors:
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 251/72
A61K 311/53
A61P 19/02
US Classification:
544194, 544206, 544207, 514241
Abstract:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]triazine compounds as inhibitors of kinases such as, for example, cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the kinases using such compounds or pharmaceutical compositions.

Pyrazolopyrimidines As Cyclin Dependent Kinase Inhibitors

View page
US Patent:
7067661, Jun 27, 2006
Filed:
Sep 3, 2003
Appl. No.:
10/653776
Inventors:
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Michael P. Dwyer - Scotch Plains NJ, US
Ronald J. Doll - Convent Station NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Carmen S. Alvarez - Livingston NJ, US
Tin-Yau Chan - Edison NJ, US
Chad Knutson - Garwood NJ, US
Vincent Madison - Mountain Lakes NJ, US
Thierry O. Fischmann - Scotch Plains NJ, US
Lawrence W. Dillard - Skillman NJ, US
Vinh D. Tran - Fountain Valley CA, US
Zhen Min He - Princeton NJ, US
Ray Anthony James - Bristol PA, US
Haengsoon Park - Plainsboro NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia Drug Discovery, Inc. - Crambury NJ
International Classification:
C07D 487/04
US Classification:
544281
Abstract:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

17Β-Hydroxysteroid Dehydrogenase Type 3 Inhibitors For The Treatment Of Androgen Dependent Diseases

View page
US Patent:
7074795, Jul 11, 2006
Filed:
Nov 14, 2003
Appl. No.:
10/713828
Inventors:
Kamil Paruch - Garwood NJ, US
Timothy J. Guzi - Chatham NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/496
C07D 401/12
US Classification:
51425301, 544360, 546188, 546190, 514316
Abstract:
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17 β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with type 3 17 β-hydroxysteroid dehydrogenase using such compounds or pharmaceutical compositions. In one embodiment, the present invention discloses a compound having the general structure shown in Formula I:wherein the various moieties are as defined herein.

Pyrazolopyrimidines As Cyclin Dependent Kinase Inhibitors

View page
US Patent:
7074924, Jul 11, 2006
Filed:
Sep 3, 2003
Appl. No.:
10/653868
Inventors:
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Michael P. Dwyer - Scotch Plains NJ, US
Ronald J. Doll - Convent Station NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Lawrence W. Dillard - Skillman NJ, US
Vinh D. Tran - Fountain Valley CA, US
Zhen Min He - Princeton NJ, US
Ray Anthony James - Bristol PA, US
Haengsoon Park - Plainsboro NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
International Classification:
C07D 487/04
US Classification:
544281
Abstract:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

Pyrazolopyrimidines As Cyclin Dependent Kinase Inhibitors

View page
US Patent:
7078525, Jul 18, 2006
Filed:
Sep 3, 2003
Appl. No.:
10/654157
Inventors:
Timothy J. Guzi - Chatham NJ, US
Kamil Paruch - Garwood NJ, US
Michael P. Dwyer - Scotch Plains NJ, US
Ronald J. Doll - Convent Station NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Lawrence W. Dillard - Skillman NJ, US
Vinh D. Tran - Fountain Valley CA, US
Zhen Min He - Princeton NJ, US
Ray Anthony James - Bristol PA, US
Haengsoon Park - Plainsboro NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
International Classification:
C07D 487/04
US Classification:
544281
Abstract:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Control profile
Kamil Paruch from Hillsborough, NJ, age ~52 Get Report